miRNAs and estrogen action
- PMID: 22503553
- PMCID: PMC3348384
- DOI: 10.1016/j.tem.2012.03.002
miRNAs and estrogen action
Abstract
MicroRNAs (miRNAs) are short, noncoding RNAs that generally base-pair within the 3' untranslated region of target mRNAs causing translational inhibition and/or mRNA degradation. Estradiol (E(2)) and other estrogen receptor (ER) ligands suppress or stimulate miRNA expression in human breast cancer cells, endometrial cells, rat mammary gland, and mouse uterus, and post-translationally regulate protein expression. Aberrant miRNA expression is implicated in estrogen-related breast and endometrial cancers, and several miRNAs downregulate ERα. The role of estrogen-regulated miRNA expression, the target genes of these miRNAs, and the role of miRNAs in health and disease is a 'hot' area of research that will yield new insight into molecular mechanisms of estrogen action.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest: none
Figures


Similar articles
-
miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA.Mol Cell Biol. 2009 Jul;29(13):3783-90. doi: 10.1128/MCB.01875-08. Epub 2009 May 4. Mol Cell Biol. 2009. PMID: 19414598 Free PMC article.
-
Estrogen Regulation of MicroRNA Expression.Curr Genomics. 2009 May;10(3):169-83. doi: 10.2174/138920209788185289. Curr Genomics. 2009. PMID: 19881910 Free PMC article.
-
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3(0 3):273-97. doi: 10.1016/j.mce.2015.01.035. Epub 2015 Feb 3. Mol Cell Endocrinol. 2015. PMID: 25659536 Free PMC article. Review.
-
MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.Cell Physiol Biochem. 2018;46(6):2601-2615. doi: 10.1159/000489687. Epub 2018 May 7. Cell Physiol Biochem. 2018. PMID: 29763890
-
MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.Int J Mol Sci. 2021 Apr 15;22(8):4072. doi: 10.3390/ijms22084072. Int J Mol Sci. 2021. PMID: 33920789 Free PMC article. Review.
Cited by
-
Plasma microRNAs in ovarian cancer--response.Clin Cancer Res. 2013 Jun 15;19(12):3326. doi: 10.1158/1078-0432.CCR-13-1022. Epub 2013 Apr 24. Clin Cancer Res. 2013. PMID: 23616635 Free PMC article. No abstract available.
-
MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.Cancer Lett. 2013 Oct 10;339(2):175-84. doi: 10.1016/j.canlet.2013.06.012. Epub 2013 Jun 18. Cancer Lett. 2013. PMID: 23791885 Free PMC article.
-
Estrogen Repression of MicroRNAs Is Associated with High Guanine Content in the Terminal Loop Sequences of Their Precursors.Biomedicines. 2017 Aug 14;5(3):47. doi: 10.3390/biomedicines5030047. Biomedicines. 2017. PMID: 28805722 Free PMC article.
-
A supervised Bayesian factor model for the identification of multi-omics signatures.Bioinformatics. 2024 May 2;40(5):btae202. doi: 10.1093/bioinformatics/btae202. Bioinformatics. 2024. PMID: 38603606 Free PMC article.
-
Structure based approaches for targeting non-coding RNAs with small molecules.Curr Opin Struct Biol. 2015 Feb;30:79-88. doi: 10.1016/j.sbi.2015.01.008. Epub 2015 Feb 16. Curr Opin Struct Biol. 2015. PMID: 25687935 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources